Skip to main content
Caplight Logo









Miramón Pharma S.L.

Miramón Pharma S.L.

Private
San SebastiánHealthcare & Life Scienceshttps://www.miramoonpharma.com/

Last Round

Seed

Nov 17, 2025

Total Funding Raised

$2.13M

Company Overview

Miramón Pharma S.L. is a biotechnology company that develops neuroprotective small molecule therapies for the treatment of degenerative and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small-molecule therapeuticsdrug discoveryneuroprotective therapyin silico drug designbiotech startuprare disease therapeuticscomputational biologyneurodegenerative diseasedrug pipelinecalcium dysregulationoxidative stressRyR modulatorpre-clinical biotechdrug licensingAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Miramón Pharma S.L. Comparables

Compare Miramón Pharma S.L. with similar companies based on industry and business-model similarity.

Miramón Pharma S.L. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeaBeLife
81%
AstronauTx
80%
Nacuity Pharmaceuticals, Inc.
78%

Miramón Pharma S.L. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 17, 2025

Key People

Founding team and executive leadership

Amalia Capilla

Chief Executive Officer

Executive Team

Iciar Arechavala Gomeza

CFO, Advisor

Executive Team

Ana Espinosa

Chief Operating Officer

Executive Team

Miramón Pharma S.L. Investors

Notable investors and investment history

Miramón Pharma S.L. investors
InvestorRounds
BIC GipuzkoaPre Seed
PinamaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 353% MoM.

Miramón Pharma S.L. Filings

Explore SEC and related filing metadata, where available.

Miramón Pharma S.L. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Miramón Pharma S.L.'s valuation, stock price, and market status.

Is Miramón Pharma S.L. a public or private company?

Miramón Pharma S.L. is a private company.

What is the current stock price of Miramón Pharma S.L.?

Miramón Pharma S.L. is a private company with no public stock price. No recent secondary market data is available.

How much is Miramón Pharma S.L. worth (valuation)?

Valuation information for Miramón Pharma S.L. is not publicly available.

Can I buy Miramón Pharma S.L. stock?

Miramón Pharma S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Miramón Pharma S.L.'s last funding round?

Miramón Pharma S.L.'s most recent funding round was Seed on November 17, 2025.

Who are the main investors in Miramón Pharma S.L.?

Key investors in Miramón Pharma S.L. include BIC Gipuzkoa, Pinama.

Will Miramón Pharma S.L. IPO soon?

No public IPO plans have been announced for Miramón Pharma S.L..

How can I track Miramón Pharma S.L. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Miramón Pharma S.L.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Sebastián
Employee Range11
Year FoundedN/A
Last FundingNov 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?